Serial Changes in Highly Sensitive Troponin I Assay and Early Diagnosis of Myocardial Infarction

被引:401
作者
Keller, Till [1 ]
Zeller, Tanja [1 ]
Ojeda, Francisco [1 ]
Tzikas, Stergios [2 ]
Lillpopp, Lars [2 ]
Sinning, Christoph [1 ]
Wild, Philipp [2 ]
Genth-Zotz, Sabine [2 ]
Warnholtz, Ascan [2 ]
Giannitsis, Evangelos [6 ]
Moeckel, Martin [7 ]
Bickel, Christoph [5 ]
Peetz, Dirk [4 ]
Lackner, Karl [3 ]
Baldus, Stephan [1 ]
Muenzel, Thomas [2 ]
Blankenberg, Stefan [1 ]
机构
[1] Univ Heart Ctr Hamburg, Dept Gen & Intervent Cardiol, Hamburg, Germany
[2] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med 2, Mainz, Germany
[3] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Lab Med, Mainz, Germany
[4] HELIOS Hosp Berlin Buch, Dept Lab Med, Berlin, Germany
[5] Fed Armed Hosp Koblenz, Dept Internal Med, Koblenz, Germany
[6] Univ Heidelberg Hosp, Dept Internal Med 3, Heidelberg, Germany
[7] Charite, Dept Cardiol, D-13353 Berlin, Germany
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2011年 / 306卷 / 24期
关键词
ACUTE CORONARY SYNDROMES; CARDIAC TROPONIN; HEART-FAILURE; BIOLOGICAL VARIATION; RISK STRATIFICATION; CLINICAL-PRACTICE; ADVERSE EVENTS; ASSOCIATION; DEFINITION; PREDICTION;
D O I
10.1001/jama.2011.1896
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Introduction of highly sensitive troponin assays into clinical practice has substantially improved the evaluation of patients with chest pain. Objective To evaluate the diagnostic performance of a highly sensitive troponin I (hsTnI) assay compared with a contemporary troponin I (cTnI) assay and their serial changes in the diagnosis of acute myocardial infarction (AMI). Design, Setting, and Patients A total of 1818 patients with suspected acute coronary syndrome were consecutively enrolled at the chest pain units of the University Heart Center Hamburg, the University Medical Center Mainz, and the Federal Armed Forces Hospital Koblenz, all in Germany, from 2007 to 2008. Twelve biomarkers including hsTnI (level of detection, 3.4 pg/mL) and cTnI (level of detection, 10 pg/mL) were measured on admission and after 3 and 6 hours. Main Outcome Measures Diagnostic performance for AMI of baseline and serial changes in hsTnI and cTnI results at 3 hours after admission to the emergency department. Results Of the 1818 patients, 413 (22.7%) were diagnosed as having AMI. For discrimination of AMI, the area under the receiver operating characteristic (ROC) curve was 0.96 (95% CI, 0.95-0.97) for hsTnI on admission and 0.92 (95% CI, 0.90-0.94) for cTnI on admission. Both were superior to the other evaluated diagnostic biomarkers. The use of hsTnI at admission (with the diagnostic cutoff value at the 99th percentile of 30 pg/mL) had a sensitivity of 82.3% and a negative predictive value (for ruling out AMI) of 94.7%. The use of cTnI (with the diagnostic cutoff value at the 99th percentile of 32 pg/mL) at admission had a sensitivity of 79.4% and a negative predictive value of 94.0%. Using levels obtained at 3 hours after admission, the sensitivity was 98.2% and the negative predictive value was 99.4% for both hsTnI and cTnI assays. Combining the 99th percentile cutoff at admission with the serial change in troponin concentration within 3 hours, the positive predictive value (for ruling in AMI) for hsTnI increased from 75.1% at admission to 95.8% after 3 hours, and for cTnI increased from 80.9% at admission to 96.1% after 3 hours. Conclusions Among patients with suspected acute coronary syndrome, hsTnI or cTnI determination 3 hours after admission may facilitate early rule-out of AMI. A serial change in hsTnI or cTnI levels from admission (using the 99th percentile diagnostic cutoff value) to 3 hours after admission may facilitate an early diagnosis of AMI. JAMA. 2011;306(24):2684-2693
引用
收藏
页码:2684 / 2693
页数:10
相关论文
共 28 条
[1]   Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction [J].
Alpert, JS ;
Antman, E ;
Apple, F ;
Armstrong, PW ;
Bassand, JP ;
de Luna, AB ;
Beller, G ;
Breithardt, G ;
Chaitman, BR ;
Clemmensen, P ;
Falk, E ;
Fishbein, MC ;
Galvani, M ;
Garson, A ;
Grines, C ;
Hamm, C ;
Jaffe, A ;
Katus, H ;
Kjekshus, J ;
Klein, W ;
Klootwijk, P ;
Lenfant, C ;
Levy, D ;
Levy, RI ;
Luepker, R ;
Marcus, F ;
Näslund, U ;
Ohman, M ;
Pahlm, O ;
Poole-Wilson, P ;
Popp, R ;
Alto, P ;
Pyörälä, K ;
Ravkilde, J ;
Rehnquist, N ;
Roberts, W ;
Roberts, R ;
Roelandt, J ;
Rydén, L ;
Sans, S ;
Simoons, ML ;
Thygesen, K ;
Tunstall-Pedoe, H ;
Underwood, R ;
Uretsky, BF ;
Van de Werf, F ;
Voipio-Pulkki, LM ;
Wagner, G ;
Wallentin, L ;
Wijns, W .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) :959-969
[2]   ANGIOGRAPHIC MORPHOLOGY AND THE PATHOGENESIS OF UNSTABLE ANGINA-PECTORIS [J].
AMBROSE, JA ;
WINTERS, SL ;
STERN, A ;
ENG, A ;
TEICHHOLZ, LE ;
GORLIN, R ;
FUSTER, V .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 5 (03) :609-616
[3]  
[Anonymous], 2007, ADV DATA
[4]  
[Anonymous], 2011, CLIN CHEM
[5]   Use of the centaur TnI-Ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome [J].
Apple, Fred S. ;
Smith, Stephen W. ;
Pearce, Lesly A. ;
Ler, Ranka ;
Murakami, MaryAnn M. .
CLINICAL CHEMISTRY, 2008, 54 (04) :723-728
[6]   High-Sensitivity Cardiac Troponin Assays: What Analytical and Clinical Issues Need to Be Addressed before Introduction into Clinical Practice? [J].
Apple, Fred S. ;
Wu, Alan ;
Collinson, Paul ;
Jaffe, Allan ;
Morrow, David .
CLINICAL CHEMISTRY, 2010, 56 (06) :886-891
[7]   Role of Monitoring Changes in Sensitive Cardiac Troponin I Assay Results for Early Diagnosis of Myocardial Infarction and Prediction of Risk of Adverse Events [J].
Apple, Fred S. ;
Pearce, Lesly A. ;
Smith, Stephen W. ;
Kaczmarek, Jason M. ;
Murakami, MaryAnn M. .
CLINICAL CHEMISTRY, 2009, 55 (05) :930-937
[8]   A simple statistical model for prediction of acute coronary syndrome in chest pain patients in the emergency department [J].
Björk J. ;
Forberg J.L. ;
Ohlsson M. ;
Edenbrandt L. ;
Öhlin H. ;
Ekelund U. .
BMC Medical Informatics and Decision Making, 6 (1)
[9]   Contribution of 30 Biomarkers to 10-Year Cardiovascular Risk Estimation in 2 Population Cohorts The MONICA, Risk, Genetics, Archiving, and Monograph (MORGAM) Biomarker Project [J].
Blankenberg, Stefan ;
Zeller, Tanja ;
Saarela, Olli ;
Havulinna, Aki S. ;
Kee, Frank ;
Tunstall-Pedoe, Hugh ;
Kuulasmaa, Kari ;
Yarnell, John ;
Schnabel, Renate B. ;
Wild, Philipp S. ;
Muenzel, Thomas ;
Lackner, Karl J. ;
Tiret, Laurence ;
Evans, Alun ;
Salomaa, Veikko .
CIRCULATION, 2010, 121 (22) :2388-U57
[10]   Association of Serial Measures of Cardiac Troponin T Using a Sensitive Assay With Incident Heart Failure and Cardiovascular Mortality in Older Adults [J].
deFilippi, Christopher R. ;
de Lemos, James A. ;
Christenson, Robert H. ;
Gottdiener, John S. ;
Kop, Willem J. ;
Zhan, Min ;
Seliger, Stephen L. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (22) :2494-2502